1-20 of 205
Franck E. Nicolini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia

Maria Agustina Perusini, Camille Kockerols, Daniela Žáčková, Franck E. Nicolini, Fausto Castagnetti, Carolina Pavlovsky, Massimo Breccia, Delphine Rea, Carmen Fava, Lynn Savoie, Christophe Bouvier, Petra Čičátková, Julien Bollard, Swe Linn, Gopila Gupta, Emilia Scalzulli, Tomoiku Takaku, Hiroshi Ureshino, Shinya Kimura, Sung-Eun Lee, Dragana Milojkovic, Andrew J Innes, Simone Claudiani, Valentín García Gutiérrez, Sr., Jiri Mayer, Peter E. Westerweel, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 3149.
https://doi.org/10.1182/blood-2024-205681
Published: 2024
Journal Articles

Outcome of Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms Ineligible for Intensive Chemotherapy or Allogeneic Hematopoietic Cell Transplantation Treated By Azacitidine Alone or in Combination - a FIM Study

Corentin Orvain, Suzanne Tavitian, Clemence Mediavilla, Francoise Boyer, Alberto Santagostino, Geoffroy Venton, Samia Madene, Tony Marchand, Pascal Turlure, Diane Lara, Lenaïg Le Clech, Katell Le Du, Jean-Baptiste Robin, Lise Willems, Anaise Blouet, Thomas Systchenko, Mathieu Wemeau, Hélène Pasquer, Melanie Mercier, Christophe Nicol, Laurence Legros, Antoine Machet, Franck E. Nicolini, Lydia Roy, Clémentine Salvado, Guillaume Denis, Elsa Lestang, Kamel Laribi, Eric Lippert, Lina Benajiba, Jean-Christophe Ianotto
Journal: Blood
Blood (2024) 144 (Supplement 1): 3167.
https://doi.org/10.1182/blood-2024-199055
Published: 2024
Journal Articles

18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Ame, Marion Simonet, Hyacinthe A Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Charlotte Doublet, Stéphane Morisset, Romaine Mayet, Gwenaëlle Garin, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2024) 144 (Supplement 1): 478.
https://doi.org/10.1182/blood-2024-198903
Published: 2024
Journal Articles

Increased Thromboinflammation Is Associated with High Thrombotic Risk in Patients with Myeloproliferative Neoplasms: A Multicentric Study of 394 Cases By the French Intergroup of Myeloproliferative Neoplasms (FIM)

Alexandre Guy, Olivier Mansier, Alexandre Catherineau, Geoffrey Garcia, Sylvie Labrouche-Colomer, Valentin Landrieu, Marie-Lise Bats, Francoise Boyer, Jean-Christophe Ianotto, Lydia Roy, Suzanne Tavitian, Borhane Slama, Stephane Girault, Gabriel Etienne, Anne Parry, Arnaud Saint-Lezer, Guillaume Denis, Clemence Mediavilla, Jean-Francois Viallard, Laurence Legros, Dana Ranta, Mathieu Wemeau, Franck E. Nicolini, Francois Lifermann, Nathalie Cambier, Luc Darnige, Francois Girodon, Juliette Soret-Dulphy, Emilie Cayssials, Fabienne Vacheret, Léa Sureau, Damien Luque-Paz, Valérie Ugo, Jean-Jacques Kiladjian, Rodolphe Thiébaut, Chloe James
Journal: Blood
Blood (2024) 144 (Supplement 1): 3133.
https://doi.org/10.1182/blood-2024-194702
Published: 2024
Journal Articles

Asciminib Shows High Efficacy and Favorable Tolerability at 80 Mg Once Daily and 40 Mg Twice Daily in Patients with Chronic Phase Chronic Myelogenous Leukemia Previously Treated with 2 or More Tyrosine Kinase Inhibitors: Primary Analysis from the ASC4OPT Study

Andreas Hochhaus, Philipp le Coutre, Dragana Milojkovic, Dennis Dong Hwan Kim, Soo Min Lim, Carolina Pavlovsky, Thanh HA Nguyen, Franck E. Nicolini, Beatriz Moiraghi, Sebastian Grosicki, Chi Dung Phu, Gabriel Etienne, Fernando Marco De Lucas, Rosa Ayala, Massimo Breccia, Charles Chuah, Giora Sharf, Roberto Abi Rached, Himanshu Pokhriyal, Santoshkumar Tota, Asmae Mirkou, Peter Schuld, Carla Boquimpani
Journal: Blood
Blood (2024) 144 (Supplement 1): 4526.
https://doi.org/10.1182/blood-2024-200017
Published: 2024
Journal Articles

Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia

Matthieu Groh, Laurène Fenwarth, Augustin Boudry, Elise Fournier, Alice Marceau-Renaut, Julie Abraham, Marly Barry, Philippe Blanche, Quentin Bodard, Thorsten Braun, Safia Chebrek, Rafael Daltro De Oliveira, Matthieu Decamp, Cécile Audrey Durel, Edouard Forcade, Mathieu Gerfaud-Valentin, Camille Golfier, Clement Gourguechon, Nathalie Grardel, Olivier Kosmider, Mathilde Labro, Sarah Melboucy Belkhir, Fatiha Merabet, Adrien Michon, Nihal Martis, Cécile Morice, Stephane Moreau, Antoine Néel, Franck E. Nicolini, Laurent Pascal, Florence Pasquier, Andrea Pieragostini, Catherine Roche-Lestienne, Philippe Rousselot, Anne Thiebaut, Jean-Francois Viallard, Mathieu Wemeau, Claude Preudhomme, Jean-Emmanuel Kahn, Guillaume Lefèvre, Nicolas Duployez
Journal: Blood
Blood (2023) 142 (Supplement 1): 78.
https://doi.org/10.1182/blood-2023-181250
Published: 2023
Journal Articles

Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure: A Report from the Residiag Study

Hippolyte Guerineau, Jean-Michel Cayuela, Stéphanie Dulucq, Violaine Tran Quang, Sihem Tarfi, Quentin Barathon, Corine Joy, Orianne Wagner-Ballon, Stéphane Morisset, Franck E. Nicolini, Lydia Roy, Sébastien Maury, Gabriel Etienne, Delphine Rea, Ivan Sloma
Journal: Blood
Blood (2023) 142 (Supplement 1): 4540.
https://doi.org/10.1182/blood-2023-186271
Published: 2023
Journal Articles

Propensity Score Matching Comparing Asciminib Versus Ponatinib in Chronic Myeloid Leukemia Patients Who Failed Prior Tyrosine Kinase Inhibitor Therapy

Maria Agustina Perusini, Camille Kockerols, Daniela Žáčková, Franck E. Nicolini, Fausto Castagnetti, Carolina Pavlovsky, Massimo Breccia, Delphine Rea, Carmen Fava, Mary Lynn Savoie, Christophe Bouvier, Petra Čičátková, Julien Bollard, Swe Mar Linn, Gopila Gupta, Emilia Scalzulli, Jiří Mayer, Peter E Westerweel, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6360.
https://doi.org/10.1182/blood-2023-190293
Published: 2023
Journal Articles

T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Amé, Marion Simonet, Hyacinthe A. Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Ludovic Fouillet, Stéphane Morisset, Isabelle Tigaud, Romaine Mayet, Gwenaëlle Garin, Jérôme Guitton, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2023) 142 (Supplement 1): 445.
https://doi.org/10.1182/blood-2023-181571
Published: 2023
Journal Articles

Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study

Laurence Legros, Francoise Huguet, Pascale Cony-Makhoul, Irit Touitou, Franck E. Nicolini, Delphine Rea, Marc G. Berger, Madalina Uzunov, Lydia Roy, Martine Escoffre Barbe, Agnes Guerci Bresler, Gabriel Etienne, Elisabeth Daguenet, Amelie Penot, Martine Gardembas Pain, Shanti Ame, Eric Jourdan, Hyacinthe A. Johnson-Ansah, Valerie Coiteux, Antoine Machet, Eric Lippert, Anne Vekoff, Jean Michel Karsenti, Stéphane Morisset, Francois Mahon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1800.
https://doi.org/10.1182/blood-2023-173132
Published: 2023
Journal Articles

Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in “Real-Life” Settings: A Population-Based Study Using a Nationwide Claim Database

Meriem Benmerad, Jules Chassetuillier, Christophe Bouvier, Pierre-Louis Lecoq, Romain Favier, Matthieu Trancart, Sandrine Hayette, Julien Bollard, Audrey Lajoinie, Franck E. Nicolini
Journal: Blood
Blood (2023) 142 (Supplement 1): 3174.
https://doi.org/10.1182/blood-2023-178703
Published: 2023
Journal Articles

Interleukin 10 (IL10) and IL15 Significantly Decreased in Chronic Myeloid Leukemia Patients Presenting with Tyrosine Kinase Inhibitor (TKI) Withdrawal Syndrome (TWS). Results from the Prospective, Explorative and Multicenter « Kiwis » Study Designed for TWS. Clinicaltrial.Gov ID: NCT03996096; Study Number: 18-206

Hyacinthe A. Johnson-Ansah, Anaïs Briant, Amandine Charbonnier, Nathalie Cambier, Gandhi Laurent Damaj, Pascal Lenain, Alexandra Henry, Jean-Jacques Parienti, David Guenet, Anne-Claire GAC Besnard, Baptiste Delapierre, Franck E. Nicolini, Brigitte Le Mauff, Marc G. Berger
Journal: Blood
Blood (2023) 142 (Supplement 1): 6335.
https://doi.org/10.1182/blood-2023-177651
Published: 2023
Journal Articles

Treatment-Free Remission after Ponatinib Cessation in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients. the Ponastop Observational Study

Franck E. Nicolini, Elisabetta Abruzzese, Gabrielle Roth-Guepin, Rami Abi-Tayeh, Vincent Alcazer, Sandrine Hayette, Stéphane Morisset, Françoise Huguet, Miriam Iezza, Fausto Castagnetti, Delphine Rea
Journal: Blood
Blood (2023) 142 (Supplement 1): 1799.
https://doi.org/10.1182/blood-2023-178326
Published: 2023
Journal Articles

Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients: Predictive Models Developed on a Nationwide Clinical and Claim Database

Jules Chassetuillier, Meriem Benmerad, Pierre-Louis Lecoq, Romain Favier, Matthieu Trancart, Sandrine Hayette, Vincent Alcazer, Christophe Bouvier, Julien Bollard, Audrey Lajoinie, Franck E. Nicolini
Journal: Blood
Blood (2023) 142 (Supplement 1): 6369.
https://doi.org/10.1182/blood-2023-179970
Published: 2023
Journal Articles

Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib Front-Line, in Real-Life Conditions: Influence of Switching to Another TKI Prior to Cessation.

Franck E. Nicolini, Vincent Alcazer, Pascale Cony-Makhoul, Stéphanie Dulucq, Sandrine Hayette, Stéphane Morisset, Rachel Parat, Christophe Bouvier, Gabriel Etienne
Journal: Blood
Blood (2022) 140 (Supplement 1): 3918–3919.
https://doi.org/10.1182/blood-2022-163376
Published: 2022
Journal Articles

Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry

Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamová, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Strömberg, Jiri Mayer, Franck E. Nicolini, Han Bao, Fausto Castagnetti, Elzbieta Patkowska, Klaus Hirschbühl, Edyta Paczkowska, Anne Parry, Astghik Voskanyan, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Krzysztof Lewandowski, Stefan W. Krause, Elke Dammann, Peter Anhut, Justyna Gil, Thomas Südhoff, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Journal: Blood
Blood (2022) 140 (Supplement 1): 818–820.
https://doi.org/10.1182/blood-2022-162252
Published: 2022
Journal Articles

Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia (CML) Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation: The Tfr-PRO Study

Giovanni Zambrotta, Sarit Assouline, Franck E. Nicolini, Elisabetta Abruzzese, Maria Cristina Miggiano, Chiara Elena, Alberto Alvarez-Larran, Ana Triguero, Alessandra Iurlo, Cristina Bucelli, Francesca Lunghi, Isabella Capodanno, Margherita Maffioli, Sara Galimberti, Giovanni Caocci, Fabio Stagno, Susanne Saussele, Carmen Fava, Philipp le Coutre, Massimiliano Bonifacio, Veronica Guglielmana, Federica Colombo, Laura Antolini, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1504–1506.
https://doi.org/10.1182/blood-2022-162207
Published: 2022
Journal Articles

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Andreas Burchert, Susanne Saussele, Christian Michel, Stephan K Metzelder, Andreas Hochhaus, Norbert Gattermann, Martina Crysandt, Philippe Schafhausen, Matthias Bormann, Markus P. Radsak, Agnès Guerci-Bresler, Thomas Illmer, Maria E Goebeler, Peter Herhaus, Lino L. Teichmann, Georg-Nikolaus Franke, Fabian Lang, Stefan W. Krause, Robert Möhle, Martine Klausmann, Frank Stegelmann, Christoph Lutz, Gabriel Etienne, Andrea Stoltefuß, Joachim R Göthert, Thomas Ernst, Andreas Neubauer, Rüdiger Hehlmann, Behnaz Aminossadati, Michael Wittenberg, Markus Pfirrmann, Carmen Schade-Brittinger, Philipp le Coutre, Franck E. Nicolini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1501–1503.
https://doi.org/10.1182/blood-2022-169324
Published: 2022
Journal Articles

Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry

Ekaterina Yu. Chelysheva, Anna Turkina, Jane F. Apperley, Mohamed A Yassin, Delphine Rea, Franck E. Nicolini, Daniela Barraco, Konstantin Kotlyarchuk, Khamida Kazakbaeva, Sukhrob Saliev, Adi Shacham, Dong-Wook Kim, Salam Al-Kindi, Penka Ganeva, Roman Shmakov, Jennifer Byrne, Harry Robertson, Cerrano Marco, Evgenia Polushkina, Malgorzata Monika Trawinska, Elisabetta Abruzzese
Journal: Blood
Blood (2022) 140 (Supplement 1): 1498–1500.
https://doi.org/10.1182/blood-2022-159993
Published: 2022
Journal Articles

Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Jorge E. Cortes, Tapan Saikia, Dong-Wook Kim, Yesid Alvarado, Franck E. Nicolini, Krishnakumar Rathnam, Navin Khattry, Sachin Punatar, Jane F. Apperley, Aude Charbonnier, Michael Deininger, Hugues de Lavallade, Nikki Granacher, Carlo Gambacorti-Passerini, Alessandro Lucchesi, Michael Mauro, Peter Vandenberghe, Gregor Verhoef, Andrew R. Whiteley, Arijit Nag, Shashikant Apte, Siu-Long Yao, Sandeep Inamdar, Ruchika Irene Dillu, Jayasree Sreenivasan, Geetanjali Chimote
Journal: Blood
Blood (2022) 140 (Supplement 1): 205–207.
https://doi.org/10.1182/blood-2022-166452
Published: 2022